Healthcare Financial News

FPIs) sold shares worth ₹9,344 crore across 16 out of the 24 sectors under consideration between November 1 and 15, according to data from National Securities Depository Ltd (NSDL). The outflow was highest in automobiles, financial services, power, information technology (IT) and fast-moving consumer goods (FMCG) while inflows were highest in healthcare, consumer services, realty and other sectors for the period. In the first 15 days of November, overseas investors were sellers to the tune of ₹1,494 crore. The automobile sector witnessed further selling by foreigners worth ₹1,722 crore in the first-half of November, after pulling ₹607 crore out of the sector in October.

LTTS), now Wipro partners with Nvidia to help healthcare companies accelerate adoption of generative artificial intelligence (gen AI) through AI-driven strategies, products, and services. “Wipro will leverage NvidiaAI Enterprise software for the production of AI across its current portfolio of healthcare solutions in Affordable Care Act (ACA), Medicare, and Medicaid to improve member experience, increase enrolment, and help support claims adjudication," Wipro said in a statement adding that this will enable healthcare organisations to achieve faster, and easier consumption of large language models (LLMs) powered by Nvidia AI Enterprise, leading to increased productivity, deeper member intelligence, and better operational efficiencies.

Gandhar Oil Refinery Gandhar Oil Refinery shares are commanding a premium of Rs 61 in the unlisted market, according to market analysts. The price band of this public issue is fixed at Rs 160-169. If the trends are sustained, the stock is expected to list at a healthy premium of 36%. The offer comprises a fresh equity issue of Rs 357 crore and an offer for sale (OFS) of Rs 143 crore.

Raamdeo Agrawal. India is in a different growth cycle, where aggregate earnings continue to grow faster than expected. The September quarter saw India Inc’s earnings grow by 32% versus expectations of about 25-26%, he said. Agrawal therefore remains bullish and sees potential for the market capitalisation to match India’s GDP by 2030. In a recent industry summit, Agrawal predicted the benchmark Nifty50 index to double over the next five years and even swell by 4 times in 10 years. Despite a rollercoaster journey, Nifty50 has given about 6% returns to investors so far in 2023. If earnings grow in double digits annually on a sustainable basis, the market is also ought to grow at a similar pace, according to Agrawal.

Tata Consultancy Services (TCS) on Tuesday said it will make a provision of $125 million in its third-quarter results in relation to a trade secret lawsuit filed by U.S.-based Epic Systems. Epic had filed the lawsuit against TCS in 2014, alleging the information technology (IT) services provider stole its intellectual property while it was contracted to implement Epic's healthcare software.

IPO) of Gandhar Oil Refinery will open for subscription on November 22. The issue closes on November 24.

When it comes to money, some people feel they have less money while others have enough to take care of their expenses. However, we all have some basic needs for which we need at least a certain amount so that we don’t face difficulties in fulfilling those needs and meeting some of our aspirations. However, assessing how much money is enough for you to live in India involves several considerations to ensure a balanced and comfortable lifestyle.

According to the business solutions provider Quess Corp, about 65 per cent of the aggregate demand emerged from Development, ERP, Automotive Design, Testing, and Administration skills.

Religare Enterprises’s shares for ₹2,116 crore – a 21.91% premium over the day’s share price. The Religare team, led by chairman Rashmi Saluja, however, resisted the Burman family's offer. Since then, there has been a flurry of accusations, casting a shadow over the future of the financial services firm.

Sankara Nethralaya in Chennai, he was a beacon of hope in the field of ophthalmology and charitable healthcare. Rama Suganthan, Vice President of the Tamil Nadu Congress, confirmed the passing of Dr Badrinath. He was 83.

Listed healthcare imaging software business Pro Medicus’ two founders began selling down $176 million worth of stock on-market just before midday, after a strong run in the company’s share price.

Cost of Living LIVE November 21: The cost of living is basically the amount of money one needs to survive in a given place - and one's most essential needs such as food, water, housing, taxes, cost of commute, healthcare, etc. The high rate of inflation has pushed up the cost of living across the globe, burning a hole in the common man's pocket.

Day trading guide for today: Indian stock market continue to trade choppy on Monday. Nifty 50 index ended 37 points lower at 19,694 levels, BSE Sensex shed 139 points and closed at 65,655 mark whereas Nifty Bank index finished marginally higher at 43,584 levels. In broad market, small-cap index ended higher and logged 0.37 per cent gain on Monday whereas mid-cap index finished marginally lower.

Thousands of families are lining up for free handouts at food banks across the Netherlands

Sectorally, buying was seen in IT, telecom, healthcare and public sector stocks while selling was seen in auto, utilities, capital goods, and FMCG stocks. Stocks that were in focus on Monday include names like Tata Investment Corporation which was up more than 15% to hit a fresh record high, Mankind Pharma rose nearly 5% and ITI Ltd closed with gains of more than 7% to hit a fresh 52-week high. We have collated a list of three stocks that either hit a fresh 52-week high, or all-time high or saw a volume or a price breakout. We spoke to an analyst on how one should look at these stocks the next trading day entirely from an educational point of view: Here’s what analyst Ankit Choudhary Co-Founder, Financial Independence Services, SEBI Registered Investment Advisors (Registration Number — INA100008939) has to say: ITI We had mentioned the re-rating of ITI when it launched its laptop and PC range under the brand name of Smash to compete against DELL, Acer and Lenovo in September. It was trading around 177 and then in October we advised existing investors to hold this stock with a stop loss of 184 as it was on the verge of giving a Pole & Flag pattern breakout above 230. The stock has seen an ATH of 337 on 18th Oct and is consolidating in a range.

In a remarkable shift, India’s real estate landscape is gearing up for a significant surge in demand, with a particular focus on senior housing. Currently, the delivery space is abuzz with 50 projects in progress from the top 12 players, and an astonishing 60% of these ventures are strategically positioned in tier 2 cities, as revealed by ASLI (The Association of Senior Living in India), which has presented a white paper in association with PWC.

₹5000 per plan/option and in multiples of Re 1. There is no upper limit for investment.

Health Ministry has released the draft National Pharmacy Commission Bill, 2023, which seeks to repeal the Pharmacy Act of 1948 and replace the Pharmacy Council of India with a national commission. The ministry put up the draft bill on its website on November 14 seeking comments from the public. The proposed bill aims to provide for a pharmacy education system that improves access to quality and affordable pharmacy or pharmaceutical education, ensures availability of adequate and high-quality pharmacy professionals in all parts of the country, promotes equitable and universal healthcare, and makes services of pharmacy professionals accessible to all citizens. The draft bill calls for a periodic and transparent assessment of pharmacy institutions, facilitating maintenance of a pharmacy register for India, and enforcing high ethical standards in all aspects of pharmacy services. It also encourages pharmacy professionals to adopt latest pharmacy research in their work and to contribute to research. The draft bill proposes flexibility to adapt to changing needs and seeks to set up an effective grievance redressal mechanism. According to the draft, the Pharmacy Ethics and Registration Board will maintain a National Pharmacy Register which will have details of pharmacy professionals to ensure transparency.

OpenAI leaders Sam Altman and Greg Brockman are poised to lead a groundbreaking AI research team at Microsoft. This strategic move comes on the heels of their departure from OpenAI, a decision that the board opted not to reverse. Microsoft's CEO, Satya Nadella, has officially confirmed that Altman and Brockman will play pivotal roles in spearheading advanced AI research initiatives within the company. Nadella in a post on X said, «We remain committed to our partnership with OpenAI and have confidence in our product roadmap, our ability to continue to innovate with everything we announced at Microsoft Ignite, and in continuing to support our customers and partners. We look forward to getting to know Emmett Shear and OAI's new leadership team and working with them. And we’re extremely excited to share the news that Sam Altman and Greg Brockman, together with colleagues, will be joining Microsoft to lead a new advanced AI research team. We look forward to moving quickly to provide them with the resources needed for their success.»

Health Ministry has sought comments from the general public on the proposed National Pharmacy Commission Bill 2023. A draft Bill was prepared and uploaded on the website of the Ministry of Health and Family Welfare (news and highlights section) on November 14. The Bill prepared by the ministry proposes to finalise the National Pharmacy Commission Bill, 2023 for setting up the National Pharmacy Commission and repealing the Pharmacy Act, 1948. The proposed draft bill calls for a comprehensive approach towards enhancing the pharmacy education system. The draft bill emphasizes improving access to quality and affordable pharmaceutical education. The proposed Bill seks to provide for a pharmacy education system that improves access to quality and affordable pharmacy or pharmaceutical education, ensures availability of adequate and high quality pharmacy professionals in all parts of the country; that promotes equitable and universal healthcare and makes services of pharmacy professionals accessible to all the citizens. The proposed Bill encourages pharmacy professionals to adopt latest pharmacy research in their work and to contribute to research.

Aurobindo Pharma Ltd lifted investor sentiments and the share prices gained of Aurobindo Pharma gained more than 1% in morning trades on Monday, on a day when benchmark indices were trading in red. Aurobindo Pharma in its filing on the exchanges said that United States Food and Drug Administration (US FDA) conducted a Pre-Approval Inspection (PAI) at Unit-I & III, Formulation manufacturing facility, of APL Healthcare Ltd., a wholly owned subsidiary of the Company, situated in the Mahabubnagar District, Telangana,, from November 13 to 17, 2023. The inspection closed with zero observations and a classification of “No Action Indicated" (NAI).